Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2005-04-30
2006-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To test if patients with Parkinson's disease who take medicines at regular time intervals have smoother symptom control.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
NCT00143026
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
NCT02615873
Levodopa Concentration Profile With Stalevo 75/125 mg
NCT01070628
A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients
NCT02448914
Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease
NCT06236230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current levodopa therapy prescribed on a regular basis three or more times per day but requiring entacapone because of 'wearing off'
* Able to manipulate electronic monitoring bottles and complete questionnaires
Exclusion Criteria
* Pregnancy or breast feeding
* Excess alcohol (over 21 units per week for women and 28 units for men)
* Mini mental state examination of less than 26.
* Severe depression (Geriatric depression score over 20)
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South Glasgow University Hospitals NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Southern General Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donald G Grosset, MBChB, MD
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern General Hospital
Glasgow, Scotland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Grant from Orion Pharma
Identifier Type: -
Identifier Source: secondary_id
R050017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.